Диссертация (1139667), страница 33
Текст из файла (страница 33)
J Am Heart Assoc. 2013;2(3): 000250.235278. Sit J, Yip V, Ko S, Gun AP, Lee JS (2007) A quasi-experimental study on acommunity-based stroke prevention programme for clients with minor stroke. J ClinNurs 16(2): 272–81.279. Snaphaan L, de Leeuw FE. Poststroke memory function in nondementedpatients: a systematic review on frequency and neuroimaging correlates. Stroke.2007;38:198–203.280. Sofi F., Valecchi D., Bacci D., Abbate R., Gensini G.F., Casini A., Macchi C.Physical activity and risk of cognitive decline: a meta-analysis of prospective studies //J.
Intern. Med. 2011; 269: 107-117.281. Sonnen J.A., Larson E.B., Crane P.K. et al. Pathological correlates of dementiain a longitudinal, population-based sample of aging // Ann. Neurol. 2007; 62: 406-413.282. SPS3 Investigators, Benavente OR, Hart RG, et al. Effects of clopidogrel addedto aspirin in patients with recent lacunar stroke. N Engl J Med. 2012;367(9):817–825.283. SPS3 Study Group, Benavente OR, Coffey CS, et al. Blood-pressure targets inpatientswithrecentlacunarstroke:theSPS3randomisedtrial.Lancet.2013;382(9891):507–515.284. Stoquart-ElSankari S, Baledent O, Gondry-Jouet C, Makki M, Godefroy O,Meyer ME.
Aging effects on cerebral blood and cerebrospinal fl uid fl ows. J CerebBlood Flow Metab. 2007;27:1563–1572.285. Strober LB, Arnett PA. Assessment of depression in three medically ill, elderlypopulations: Alzheimer’s disease, Parkinson’s disease, and stroke. Clin Neuropsychol.2009;23(2):205–230.286. Strong K, Mathers C, Bonita R (2007) Preventing stroke: saving lives around theworld.
Lancet Neurol 6(2): 182–187.287. Sundar U., Adwani S. Post-stroke cognitive impairment after 3 months. AnnIndian Acad Neurol 2010;13(1):42–6.288. Tamam B., Tasdemir N., Tamam Y. The prevalence of dementia 3 months afterstroke and it’s risk factors. Turk Psikhiatri Derq 2008;19(1):46–56.236289. Tangney C.C., Kwasny M.J., Li H., Wilson R.S., ¬Evans D.A., Morris M.C.Adherence to a Mediterranean-type dietary pattern and cognitive decline in acommunity population // Am. J. Clin.
Nutr. 2011; 93: 601-607.290. Tharwani H, Yerramsetty P, Mannelli P, Patkar A, Masand P. Recent advancesin poststroke depression. Curr Psychiatry Rep. 2007;9(3): 225–231.291. The European Registers of Stroke (EROS) Investigators. Incidence of stroke inEurope at the beginning of the 21st century. Stroke. 2009;40(5):1557–1563.292. Uchiyama S, Ikeda Y, Urano Y, Horie Y, Yamaguchi T. The Japanese aggrenox(extended-release dipyridamole plus aspirin) stroke prevention versus aspirinprogramme (JASAP) study: A randomized, double-blind, controlled trial.
CerebrovascDis. 2011;31:601-613.293. Van Nes M, Sawatzky J (2010) Improving cardiovascular health withmotivational interviewing: A nurse practitioner perspective. J Am Acad Nurse Pract 22:654–60.294. Vernooij M.W., van der Lugt A., Ikram M.A. et al. Prevalence and risk factorsof cerebral microbleeds: the Rotterdam Scan Study // Neurology. 2008; 70: 1208-1214.295.
Wang Y, Wang Y, Zhao X, et al; CHANCE Investigators. Clopidogrel withaspirin in acute minor stroke or transient ischemic attack. N Engl J Med.2013;369(1):11–19.296. Wanyong Yang, Anding Xu, Feng Qi, Yan Huang, Ke Yu, Youjia Li, et al.APilot Trial of Clopidogrel of Loading Dosage to Treat non Cardioembolic AcuteIschemic Stroke/Transient Ischemic Attack in China. Lancet Neurol.
2013; 9: 489–497.297. Watkins C, Auton M, Deans C, et al. Motivational interviewing early after acutestroke: a randomized, controlled trial. Stroke. 2007;38(3):1004–1009.298. Willey JZ, Moon YP, Kahn E, et al. Population attributable risks of hypertensionand diabetes for cardiovascular disease and stroke in the northern Manhattan study. JAm Heart Assoc. 2014;3(5): 001106.299.
Wolfe CDA, Redfern J, Rudd AG, Grieve AP, Heuschmann PU, McKevitt C(2010) Cluster Randomized Controlled Trial of a Patient and General Practitioner237Intervention to Improve the Management of Multiple Risk Factors After Stroke StopStroke. Stroke 41: 2470–2476.300. Wong GK, Lam S, Ngai K, Wong A, Mok V, Poon WS Evaluation of cognitiveimpairment by the Montreal cognitive assessment in patients with aneurysmalsubarachnoid haemorrhage: prevalence, risk factors and correlations with 3 monthoutcomes. J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1112-7.301.
Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, et al.Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients withacute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised,open-label, blinded-endpoint trial. Lancet Neurol. 2010; 9: 489–497.302. World Health Organisation (2011) Global Atlas on Cardiovascular DiseasePrevention and Control. Accessed 05 December 2014.303. Xu A., Lin Y., Genq J.L.
et al. The prevalence and risk factors for cognitiveimpairment following ischemic stroke. Zhanghua Nei Za Zhi 2008;12:981–4.304. Yu KH, Cho SJ, Oh MS, Jung S, Lee JH, Shin JH, Koh IS, Cha JK, Park JM,Bae HJ, Kang Y, Lee BC Cognitive Impairment Evaluated With Vascular CognitiveImpairment Harmonization Standards in a Multicenter Prospective Stroke Cohort inKorea.
Stroke. 2012 Dec 27.305. Zinn S., Bosworth H.B., Hoenig H.M., Swartzwelder H.S. Executive functiondeficits in acute stroke // Arch. Phys. Med. Rehabil. 2007; 88: 173-80..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
